Persistent URL of this record https://hdl.handle.net/1887/112990
In Collections
This item can be found in the following collections:
Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review
- All authors
- Arts-de Jong, M.; Bock, G.H. de; Asperen, C.J. van; Mourits, M.J.E.; Hullu, J.A. de; Kets, C.M.
- Date
- 2016-07-31
- Journal
- European Journal of Cancer
- Volume
- 61
- Pages
- 137 - 145